Literature DB >> 21454882

Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma.

Franziska C Eberle1, Jaime Rodriguez-Canales, Lai Wei, Jeffrey C Hanson, J Keith Killian, Hong-Wei Sun, Lisa G Adams, Stephen M Hewitt, Wyndham H Wilson, Stefania Pittaluga, Paul S Meltzer, Louis M Staudt, Michael R Emmert-Buck, Elaine S Jaffe.   

Abstract

BACKGROUND: Mediastinal gray zone lymphoma is a newly recognized entity with transitional morphological and immunophenotypic features between the nodular sclerosis subtype of Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. Diagnostic criteria for mediastinal gray zone lymphoma are still challenging, and the optimal therapy is as yet undetermined. Epigenetic changes have been implicated in the loss of the B-cell program in classical Hodgkin's lymphoma, and might provide a basis for the immunophenotypic alterations seen in mediastinal gray zone lymphoma. DESIGN AND METHODS: We performed a large-scale DNA methylation analysis of microdissected tumor cells to investigate the biological underpinnings of mediastinal gray zone lymphoma and its association with the related entities classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma, making comparisons with the presumptively less related diffuse large B-cell lymphoma.
RESULTS: Principal component analysis demonstrated that mediastinal gray zone lymphoma has a distinct epigenetic profile intermediate between classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma but remarkably different from that of diffuse large B-cell lymphoma. Analysis of common hypo- and hypermethylated CpG targets in mediastinal gray zone lymphoma, classical Hodgkin's lymphoma, primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma was performed and confirmed the findings of the principal component analysis. Based on the epigenetic profiles we were able to establish class prediction models utilizing genes such as HOXA5, MMP9, EPHA7 and DAPK1 which could distinguish between mediastinal gray zone lymphoma, classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma with a final combined prediction of 100%.
CONCLUSIONS: Our data confirm a close relationship between mediastinal gray zone lymphoma and both classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma. However, important differences were observed as well, allowing a clear distinction from both parent entities. Thus, mediastinal gray zone lymphoma cannot be assigned to either classical Hodgkin's lymphoma or primary mediastinal large B-cell lymphoma, validating the decision to create an intermediate category in the World Health Organization classification.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454882      PMCID: PMC3069233          DOI: 10.3324/haematol.2010.033167

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  40 in total

Review 1.  Epigenetic changes in the myelodysplastic syndrome.

Authors:  Jean-Pierre Issa
Journal:  Hematol Oncol Clin North Am       Date:  2010-04       Impact factor: 3.722

2.  New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling.

Authors:  José I Martín-Subero; Markus Kreuz; Marina Bibikova; Stefan Bentink; Ole Ammerpohl; Eliza Wickham-Garcia; Maciej Rosolowski; Julia Richter; Lidia Lopez-Serra; Esteban Ballestar; Hilmar Berger; Xabier Agirre; Heinz-Wolfram Bernd; Vincenzo Calvanese; Sergio B Cogliatti; Hans G Drexler; Jian-Bing Fan; Mario F Fraga; Martin L Hansmann; Michael Hummel; Wolfram Klapper; Bernhard Korn; Ralf Küppers; Roderick A F Macleod; Peter Möller; German Ott; Christiane Pott; Felipe Prosper; Andreas Rosenwald; Carsten Schwaenen; Dirk Schübeler; Marc Seifert; Benjamin Stürzenhofecker; Michael Weber; Swen Wessendorf; Markus Loeffler; Lorenz Trümper; Harald Stein; Rainer Spang; Manel Esteller; David Barker; Dirk Hasenclever; Reiner Siebert
Journal:  Blood       Date:  2008-12-15       Impact factor: 22.113

3.  Differential efficacy of bortezomib plus chemotherapy within molecular subtypes of diffuse large B-cell lymphoma.

Authors:  Kieron Dunleavy; Stefania Pittaluga; Myron S Czuczman; Sandeep S Dave; George Wright; Nicole Grant; Margaret Shovlin; Elaine S Jaffe; John E Janik; Louis M Staudt; Wyndham H Wilson
Journal:  Blood       Date:  2009-04-20       Impact factor: 22.113

Review 4.  Histopathology of Hodgkin's lymphoma.

Authors:  Franziska C Eberle; Haresh Mani; Elaine S Jaffe
Journal:  Cancer J       Date:  2009 Mar-Apr       Impact factor: 3.360

5.  Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas.

Authors:  K Amara; M Trimeche; S Ziadi; A Laatiri; M Hachana; S Korbi
Journal:  Ann Oncol       Date:  2008-06-06       Impact factor: 32.976

6.  Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.

Authors:  S Eckerle; V Brune; C Döring; E Tiacci; V Bohle; C Sundström; R Kodet; M Paulli; B Falini; W Klapper; A B Chaubert; K Willenbrock; D Metzler; A Bräuninger; R Küppers; M-L Hansmann
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

Review 7.  Epigenetic biomarkers for human cancer: the time is now.

Authors:  Sonia Mulero-Navarro; Manel Esteller
Journal:  Crit Rev Oncol Hematol       Date:  2008-04-21       Impact factor: 6.312

8.  Large-scale profiling of archival lymph nodes reveals pervasive remodeling of the follicular lymphoma methylome.

Authors:  J Keith Killian; Sven Bilke; Sean Davis; Robert L Walker; M Scott Killian; Erich B Jaeger; Yidong Chen; Jason Hipp; Stefania Pittaluga; Mark Raffeld; Robert Cornelison; William I Smith; Marina Bibikova; Jian-Bing Fan; Michael R Emmert-Buck; Elaine S Jaffe; Paul S Meltzer
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

9.  A comprehensive microarray-based DNA methylation study of 367 hematological neoplasms.

Authors:  Jose I Martin-Subero; Ole Ammerpohl; Marina Bibikova; Eliza Wickham-Garcia; Xabier Agirre; Sara Alvarez; Monika Brüggemann; Stefanie Bug; Maria J Calasanz; Martina Deckert; Martin Dreyling; Ming Q Du; Jan Dürig; Martin J S Dyer; Jian-Bing Fan; Stefan Gesk; Martin-Leo Hansmann; Lana Harder; Sylvia Hartmann; Wolfram Klapper; Ralf Küppers; Manuel Montesinos-Rongen; Inga Nagel; Christiane Pott; Julia Richter; José Román-Gómez; Marc Seifert; Harald Stein; Javier Suela; Lorenz Trümper; Inga Vater; Felipe Prosper; Claudia Haferlach; Juan Cruz Cigudosa; Reiner Siebert
Journal:  PLoS One       Date:  2009-09-11       Impact factor: 3.240

10.  Array-based DNA methylation profiling in follicular lymphoma.

Authors:  C O'Riain; D M O'Shea; Y Yang; R Le Dieu; J G Gribben; K Summers; J Yeboah-Afari; L Bhaw-Rosun; C Fleischmann; C A Mein; T Crook; P Smith; G Kelly; A Rosenwald; G Ott; E Campo; L M Rimsza; E B Smeland; W C Chan; N Johnson; R D Gascoyne; S Reimer; R M Braziel; G W Wright; L M Staudt; T A Lister; J Fitzgibbon
Journal:  Leukemia       Date:  2009-07-09       Impact factor: 11.528

View more
  36 in total

Review 1.  Aggressive B-cell lymphomas: a review of new and old entities in the WHO classification.

Authors:  Elaine S Jaffe; Stefania Pittaluga
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2011

2.  My treatment approach to patients with diffuse large B-cell lymphoma.

Authors:  James O Armitage
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

Review 3.  The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.

Authors:  Alexander Marx; John K C Chan; Jean-Michel Coindre; Frank Detterbeck; Nicolas Girard; Nancy L Harris; Elaine S Jaffe; Michael O Kurrer; Edith M Marom; Andre L Moreira; Kiyoshi Mukai; Attilio Orazi; Philipp Ströbel
Journal:  J Thorac Oncol       Date:  2015-10       Impact factor: 15.609

4.  Plasma DNA methylation of p16 and shp1 in patients with B cell non-Hodgkin lymphoma.

Authors:  Kai Ding; Xiaoshuang Chen; Yihao Wang; Hui Liu; Wenjing Song; Lijuan Li; Guojin Wang; Jia Song; Zonghong Shao; Rong Fu
Journal:  Int J Clin Oncol       Date:  2017-02-16       Impact factor: 3.402

5.  Mediastinal gray zone lymphoma.

Authors:  Leticia Quintanilla-Martinez; Falko Fend
Journal:  Haematologica       Date:  2011-04       Impact factor: 9.941

Review 6.  The histological classification of diffuse large B-cell lymphomas.

Authors:  Yi Xie; Stefania Pittaluga; Elaine S Jaffe
Journal:  Semin Hematol       Date:  2015-01-17       Impact factor: 3.851

Review 7.  Diffuse large B-cell lymphoma-treatment approaches in the molecular era.

Authors:  Mark Roschewski; Louis M Staudt; Wyndham H Wilson
Journal:  Nat Rev Clin Oncol       Date:  2013-11-12       Impact factor: 66.675

8.  Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association.

Authors:  Clémentine Sarkozy; Thierry Molina; Hervé Ghesquières; Anne-Sophie Michallet; Jehan Dupuis; Diane Damotte; Franck Morsschauser; Marie Parrens; Laurent Martin; Peggy Dartigues; Aspasia Stamatoullas; Pierre Hirsch; Bettina Fabiani; Krimo Bouabdallah; Maria Gomes da Silva; Marie Maerevoet; Camille Laurent; Bertrand Coiffier; Gilles Salles; Alexandra Traverse-Glehen
Journal:  Haematologica       Date:  2016-10-06       Impact factor: 9.941

Review 9.  Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?

Authors:  Kieron Dunleavy; Wyndham H Wilson
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

Review 10.  [Lymph node pathology - an update].

Authors:  S Hartmann; M L Hansmann
Journal:  Pathologe       Date:  2013-02       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.